Greenleaf Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Greenleaf Trust’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,608	Closed	-$212K	–	798
2023 Q4	$212K	Buy	+3,608	New	+$203K	﹤0.01%	708

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Greenleaf Trust's MRTX Position: Q1 2024 in Review

Greenleaf Trust sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 3,608 shares — an estimated $212K sold.

Greenleaf Trust first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $212K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Greenleaf Trust reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Greenleaf Trust sold 3,608 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $212K.
Greenleaf Trust first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Greenleaf Trust's Mirati Therapeutics, Inc. Common Stock position peaked at $212K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Greenleaf Trust's 13F filing for Q1 2024, filed 29 Apr 2024.